| Type | Title | Date Released | |
|---|---|---|---|
6-K | Biotechnology Company Announces 1-for-20 Reverse Stock Split Effective October 26 to Regain Nasdaq Minimum Bid Compliance | ||
6-K | Cellyan Biotechnology Co., Ltd Announces Resignation of Independent Director Mike Yao Zhou and Appointment of Letao Zhao | ||
6-K | Cellyan Biotechnology Co., Ltd Announces Results of Extraordinary General Meeting Approving Share Consolidation and M&A Amendment | ||
6-K | Cellyan Biotechnology Co., Ltd Announces Extraordinary General Meeting for Proposed 1-for-20 Share Consolidation | ||
S-8 | Form S-8 | ||
20-F | Form 20-F | ||
NT 20-F | Form NT 20-F | ||
6-K | Cellyan Biotechnology Co., Ltd Granted 180-Day Extension to Regain Nasdaq Compliance | ||
EFFECT | Form EFFECT | ||
F-3 | June 2026 SHELF | ||
3 | CHAN Kam Leung (Reporting) | ||
3 | Wong Lap Sun (Reporting) |